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Abstract. Repeated amphetamine (AMPH) administra- 
tion into the nucleus accumbens does not enhance (sen- 
sitize) the locomotor activity produced by a subsequent 
systemic AMPH challenge. We report here, however, 
that pretreatment with systemic injections of AMPH 
does produce a significant enhancement in the locomotor 
stimulant effects produced by intra-accumbens AMPH 
given 21 days after the last pretreatment injection of 
AMPH. These data support the hypothesis that neural 
adaptations in dopamine (DA) terminal fields are suf- 
ficient for the expression of AMPH sensitization, al- 
though an action on DA cell bodies may be required for 
the induction of AMPH sensitization. 
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The intermittant administration of amphetamine 
(AMPH) produces an enduring enhancement in the mo- 
tor stimulant effects of AMPH, a phenomenon known as 
behavioral sensitization. Behavioral sensitization to 
AMPH is thought to be due, at least in part, to enduring 
changes in mesotelencephalic dopamine (DA) systems, 
although the locus and nature of the neuronal adapta- 
tions responsible for sensitization have not been well 
characterized (see Robinson and Becker 1986 for review). 
A number of researchers have suggested that an ac- 
tion of AMPH in the midbrain, at the level of the DA cell 
bodies, is necessary for the induction of behavioral sen- 
sitization. For example, repeated AMPH injections into 
the ventral tegmental area, but not into the DA terminal 
field in the nucleus accumbens, produce an enhanced 
locomotor response to subsequent peripheral ad- 
ministration of morphine or psychomotor stimulant 
Offprint requests to: T.E. Robinson 
drugs (Dougherty et al. 1981; Kalivas and Weber 1988; 
Vezina and Stewart 1990). Also, the local microinjection 
of a D A D  1 receptor antagonist into the ventral tegmen- 
tal area is sufficient to prevent the development of behav- 
ioral sensitization to systemic AMPH treatment (Stewart 
and Vezina 1989). The idea that an action of AMPH on 
DA cell bodies is required to induce sensitization is con- 
sistent with evidence that the protein synthesis inhibitor, 
anisomycin, prevents the development of AMPH sen- 
sitization (Robinson 1991). 
Although the induction of behavioral sensitization 
may require an action of AMPH at the cell bodies, the 
expression of sensitization may not. There is considerable 
evidence showing that the ability of AMPH to enhance 
locomotor activity is primarily due to its action in DA 
terminal fields, where it causes DA release. For example, 
the acute intra-accumbens application of AMPH or DA 
produces marked locomotor hyperactivity, whereas, ad- 
ministration into the ventral tegmental area does not. 
Also, a sensitization-related enhancement in DA release 
is seen in striatal or nucleus accumbens tissue slices, a 
preparation in which no cell bodies are present (Robin- 
son and Becker 1982; Kolta et al. 1989). We hypoth- 
esized, therefore, that the induction of behavioral sen- 
sitization may require an action of AMPH in DA soma- 
todendritic regions, but the expression of sensitization is 
due to changes in the responsivity to AMPH in DA 
terminal fields. If this hypothesis is correct, animals sen- 
sitized by systemic treatment with AMPH should be 
behaviorally hyper-responsive to a subsequent local 
AMPH challenge into the nucleus accumbens. The pur- 
pose of the experiment reported here was to test this 
hypothesis. 
Female Holtzman rats weighing 200-250 g at the start 
of the experiment were injected with either saline (n = t 0) 
or escalating doses (1-10 mg/kg) of d-AMPH sulfate 
(n = 13) twice daily on each consecutive weekday for 
6 weeks, but not on weekends (see Robinson and Camp 
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Fig. 1. The mean number of crossovers from one side of the test 
chamber to the other (locomotor activity) recorded for the 1 h 
following an intra-accumbens injection of saline (0-60 min) and for 
1 h following the intra-accumbens injection of 10 gg amphetamine 
(65-120 min). Animals were tested 3 weeks after discontinuation of 
pretreatment with either saline (open symbols) or escalating doses 
(1-10 mg/kg) of amphetamine (closed symbols) 
weeks after the discontinuation of  pretreatment,  23 g 
guide cannulae were stereotaxically placed 2.6 m m  below 
the surface of  the neocortex, bilaterally, above the nu- 
cleus accumbens in each hemisphere. One week after 
surgery (20 days after the last pretreatment  injection) 
animals were placed into automated  activity moni tors  
(41 x 24 x 18 cm), which are described in detail elsewhere 
(Robinson and Camp 1987), and allowed to habituate 
overnight. The next morning 30 g microinjection can- 
nulae were lowered into the nucleus accumbens in both 
hemispheres via the guide cannulae, and fixed in place. 
After 1 min, 0.5 gl 0.9% saline was infused over a period 
of 1 min using a Harvard  syringe pump,  and the injection 
cannulae left in place for an additional minute, before 
being removed. Locomoto r  activity (crossovers) was re- 
corded in 5-min intervals over the next hour. Next,  the 
injection cannulae were lowered again and 10gg 
d -AMPH,  in a volume of  0.5 lal, was administered to each 
animal using the same procedure as described for saline. 
This dose was based on previous studies showing that it 
was effective in inducing locomotor  activity- (Carr and 
White 1987). The injection cannulae were removed I min 
later, and locomotor  activity was recorded for the next 
hour. Only animals with cannulae located bilaterally 
within the nucleus accumbens, verified histologically, 
were included in the analysis. 
Saline infusion and the associated handling produced 
a very small increase in locomotor  activity that  subsided 
within 10 min (Fig. 1). There was, however, no effect of  
pretreatment  condition. In contrast,  intra-accumbens 
A M P H  produced a marked increase in locomotor  activ- 
ity that  peaked 20 min after the injection and then slowly 
subsided over the 1-h observation period (Fig. 1). The 
increase in locomotor  activity produced by intra-accum- 
bens A M P H  was significantly greater in animals pre- 
treated with A M P H  than in saline-pretreated controls 
(F = 5.79, P <  0.02). 
In summary,  pretreatment  with systemic injections of  
A M P H  produced a significant enhancement in the loco- 
motor  stimulant effects of  intra-accumbens A M P H  given 
21 days after the last pretreatment  injection of  A M P H  
(also see Rebec and Segal 1979; Kol ta  et al. 1989). These 
data support  the hypothesis that neural adaptat ions in 
D A  terminal fields are sufficient for the expression of  
A M P H  sensitization, al though an action on D A  cell 
bodies may be required for the induction of  A M P H  sen- 
sitization. 
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